Inquiry Basket
Loading ......
Filter By Product Search for
ARX
ARX Full Name
aristaless related homeobox
ARX Introduction
The Aristaless-related homeobox (ARX) is a highly conserved, paired-type homeodomain transcription factor that functions as a master genetic regulator during embryonic development. Located on the X chromosome, the ARX gene is predominantly expressed in the central nervous system, pancreas, and testes. In the developing forebrain, ARX acts primarily as a transcriptional repressor to meticulously govern the proliferation, differentiation, and tangential migration of GABAergic interneurons—the principal inhibitory cells of the cerebral cortex. Beyond neurogenesis, ARX plays an indispensable role in the endocrine system. Within the developing pancreas, it dictates the cellular fate of endocrine progenitors by actively promoting the specification of glucagon-producing alpha cells while simultaneously repressing the insulin-producing beta cell lineage.
Figure 1. Schematic representation of the homeobox transcription factor Arx. (Source: Tsuboi A, et al. 2025)
Clinically, genetic mutations in ARX—ranging from polyalanine tract expansions to severe missense mutations—are responsible for a devastating spectrum of X-linked neurodevelopmental disorders. The most severe structural manifestation is X-linked lissencephaly with abnormal genitalia (XLAG), a condition characterized by a smooth brain lacking normal cortical folding. Non-malformation phenotypes typically present as early infantile epileptic encephalopathies (EIEEs), such as West syndrome and Ohtahara syndrome, which are frequently accompanied by severe intellectual disability. These neuropathologies arise because defective ARX profoundly impairs interneuron migration, creating a catastrophic imbalance between excitatory and inhibitory neural signaling that ultimately manifests as intractable seizures. Interestingly, in the context of metabolic medicine, the targeted epigenetic silencing of ARX in pancreatic alpha cells is currently being explored as a revolutionary cellular reprogramming strategy. By suppressing ARX locally, researchers can induce the conversion of mature alpha cells into insulin-producing beta cells, offering a highly promising therapeutic avenue for treating type 1 diabetes.
Alternate Names for ARX
ARX; aristaless related homeobox; mental retardation, X linked 29; mental retardation, X linked 32; mental retardation, X linked 33; mental retardation, X linked 36; mental retardation, X linked 38; mental retardation, X linked 43; mental retardation, X linked 54; mental retardation, X linked 76
Loading ......
